Glaxo's Win in Case Against Teva Lifts Other Drugmakers - Bloomberg
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma
Teva Is On The Prowl And Its Investors Are Taking Notice | Mint
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva Agrees to Stop Selling Amgen Generic Following Patent Infringement Settlement | Ctech
Teva Is Exploring Mylan Bid to Create Generic-Drug Giant - Bloomberg
Teva's CEO on Why the Drugmaker Is Confident Despite Covid-19 | Barron's
Actavis CEO: Teva-Mylan deal could be "value-destroying" - גלובס
Teva Pharmaeutical Stock Gets Upgrade From Analyst | Barron's
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva: Reportedly Planning Thousands of Layoffs in the U.S. | Fortune
Teva, Some Units Fueled Opioid Crisis, N.Y. Jury Concludes (2)
Teva's CEO Was $2.8 Billion Down on His Second Day on the Job - Bloomberg
Teva sees close of $40.5B Allergan generics deal by June - BNN Bloomberg
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion
Watch Mylan Board Rejects $40.1B Teva Takeover Bid - Bloomberg
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Teva, Allergan ready to pay $5B to settle thousands of opioid lawsuits (TEVA) | Seeking Alpha
